This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Han, K. O. Articles by Han, I. K. Search for Related Content PubMed PubMed Citation Articles by Han, K. O. Articles by Han, I. K.

Nonassociation of Estrogen Receptor Genotypes with Bone Mineral Density and Estrogen Responsiveness to Hormone Replacement Therapy in Korean Postmenopausal Women

Department of Internal Medicine (K.O.H., H.Y.C., H.K.M., I.K.H.) and Endocrinology Research Laboratory (I.G.M., Y.S.K.), Samsung Cheil Women’s Healthcare Center, Seoul, Korea

Address all correspondence and requests for reprints to: Dr. In Kwon Han, Department of Internal Medicine, Samsung Cheil Women’s Healthcare Center, 1–19 Choong Gu Mukjung-Dong, 100–380 Seoul, Korea.

Hormone replacement therapy (HRT) prevents bone loss in postmenopausal women, but some women are resistant to therapy. A recently reported case of severe estrogen resistance caused by a germ-line mutation at the estrogen receptor (ER) gene locus suggests the possibility that other variants of the ER gene could be responsible for resistance to HRT and could also be an answer to the heritable components of bone density. Three restriction fragment length polymorphisms (RFLPs) at the ER gene locus, represented as BstUI (or B variant), PvuII, and XbaI, and their relationship to bone mineral density (BMD) and estrogen responsiveness to HRT were examined in 248 healthy postmenopausal women, aged 41–68 yr (mean ± SD, 52.0 ± 4.6 yr) in Korea. The BstUI restriction site was not found in Korean women. The distribution of the PvuII and XbaI RFLPs was as follows: PP, 35 (14.1%); Pp, 136 (54.8%); pp, 77 (31.1%); and XX, 18 (7.3%); Xx, 72 (29.0%); and xx, 158 (63.7%), respectively (capital letters signify the absence of and lower case letters signify the presence of the restriction site of each RFLP). There was no significant relation between ER genotypes and z score values of lumbar spine BMD. Also, no significant genotypic differences were found in the change in lumbar spine BMD and those in biochemical markers before and after 1 yr of HRT. These data indicate no significant effects of ER genotypes on BMD and estrogen responsiveness after HRT.

This article has been cited by other articles:

				T. Yahata, J. Quan, N. Tamura, H. Nagata, T. Kurabayashi, and K. Tanaka Association between single nucleotide polymorphisms of estrogen receptor {alpha} gene and efficacy of HRT on bone mineral density in post-menopausal Japanese women Hum. Reprod., July 1, 2005; 20(7): 1860 - 1866. [Abstract] [Full Text] [PDF]

				L. Gennari, D. Merlotti, V. De Paola, A. Calabro, L. Becherini, G. Martini, and R. Nuti Estrogen Receptor Gene Polymorphisms and the Genetics of Osteoporosis: A HuGE Review Am. J. Epidemiol., February 15, 2005; 161(4): 307 - 320. [Abstract] [Full Text] [PDF]

				S. Khosla, B. L. Riggs, E. J. Atkinson, A. L. Oberg, C. Mavilia, F. Del Monte, L. J. Melton III, and M. L. Brandi Relationship of Estrogen Receptor Genotypes to Bone Mineral Density and to Rates of Bone Loss in Men J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1808 - 1816. [Abstract] [Full Text] [PDF]

				Q. Cai, X.-O. Shu, F. Jin, Q. Dai, W. Wen, J.-R. Cheng, Y.-T. Gao, and W. Zheng Genetic Polymorphisms in the Estrogen Receptor {alpha} Gene and Risk of Breast Cancer: Results from the Shanghai Breast Cancer Study Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 853 - 859. [Abstract] [Full Text] [PDF]

				S. Palomba, F. G. Numis, G. Mossetti, D. Rendina, P. Vuotto, T. Russo, F. Zullo, C. Nappi, and V. Nunziata Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes Hum. Reprod., January 1, 2003; 18(1): 192 - 198. [Abstract] [Full Text] [PDF]

				M. Peacock, C. H. Turner, M. J. Econs, and T. Foroud Genetics of Osteoporosis Endocr. Rev., June 1, 2002; 23(3): 303 - 326. [Abstract] [Full Text] [PDF]

				D. M. Herrington, T. D. Howard, G. A. Hawkins, D. M. Reboussin, J. Xu, S. L. Zheng, K. B. Brosnihan, D. A. Meyers, and E. R. Bleecker Estrogen-Receptor Polymorphisms and Effects of Estrogen Replacement on High-Density Lipoprotein Cholesterol in Women with Coronary Disease N. Engl. J. Med., March 28, 2002; 346(13): 967 - 974. [Abstract] [Full Text] [PDF]

				A Nemetz, M Toth, M A Garcia-Gonzalez, T Zagoni, J Feher, A S Pena, and Z Tulassay Allelic variation at the interleukin 1{beta} gene is associated with decreased bone mass in patients with inflammatory bowel diseases Gut, November 1, 2001; 49(5): 644 - 649. [Abstract] [Full Text] [PDF]

				J. A. Eisman Pharmacogenetics of the Vitamin D Receptor and Osteoporosis Drug Metab. Dispos., April 1, 2001; 29(4): 505 - 512. [Abstract] [Full Text]

				L. Becherini, L. Gennari, L. Masi, R. Mansani, F. Massart, A. Morelli, A. Falchetti, S. Gonnelli, G. Fiorelli, A. Tanini, et al. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor {alpha} gene and their relationship to bone mass variation in postmenopausal Italian women Hum. Mol. Genet., August 12, 2000; 9(13): 2043 - 2050. [Abstract] [Full Text] [PDF]

				B. D. Mitchell, S. A. Cole, R. L. Bauer, S. J. Iturria, E. A. Rodriguez, J. Blangero, J. W. MacCluer, and J. E. Hixson Genes Influencing Variation in Serum Osteocalcin Concentrations Are Linked to Markers on Chromosomes 16q and 20q J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1362 - 1366. [Abstract] [Full Text]

				E. Weiderpass, I. Persson, H. Melhus, S. Wedren, A. Kindmark, and J. A. Baron Estrogen receptor {alpha} gene polymorphisms and endometrial cancer risk Carcinogenesis, April 1, 2000; 21(4): 623 - 627. [Abstract] [Full Text] [PDF]

				J. A. Eisman Genetics of Osteoporosis Endocr. Rev., December 1, 1999; 20(6): 788 - 804. [Abstract] [Full Text]

				Estrogen Receptor Gene Polymorphism, But Not Estradiol Levels, Is Related to Bone Density in Healthy Adolescent Boys: A Cross-Sectional and Longitudinal Study J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4597 - 4601. [Abstract] [Full Text]

				C. Sundarrajan, W.-X. Liao, A.C. Roy, and S.C. Ng Association of oestrogen receptor gene polymorphisms with outcome of ovarian stimulation in patients undergoing IVF Mol. Hum. Reprod., September 1, 1999; 5(9): 797 - 802. [Abstract] [Full Text] [PDF]

				A. G. Uitterlinden, H. Burger, Q. Huang, F. Yue, F. E.A. McGuigan, S. F.A. Grant, A. Hofman, J. P.T.M. van Leeuwen, H. A.P. Pols, and S. H. Ralston Relation of Alleles of the Collagen Type I{alpha}1 Gene to Bone Density and the Risk of Osteoporotic Fractures in Postmenopausal Women N. Engl. J. Med., April 9, 1998; 338(15): 1016 - 1021. [Abstract] [Full Text] [PDF]

				Y. Matsubara, M. Murata, K. Kawano, T. Zama, N. Aoki, H. Yoshino, G. Watanabe, K. Ishikawa, and Y. Ikeda Genotype Distribution of Estrogen Receptor Polymorphisms in Men and Postmenopausal Women From Healthy and Coronary Populations and Its Relation to Serum Lipid Levels Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3006 - 3012. [Abstract] [Full Text]

				D. A. Nelson and M. Kleerekoper M.D. The Search for the Osteoporosis Gene J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 989 - 990. [Full Text] [PDF]